Prolynx Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Prolynx is a biotechnology company based in San Francisco, California, focused on creating medicines with extended duration for obesity and related metabolic diseases. The firm is building a portfolio of therapies designed for monthly or quarterly administration, aiming to smooth peak and trough drug levels to improve tolerability and support more consistent, long-term outcomes. It remains a relatively small player within the biotechnology research space, concentrating on metabolic disease therapeutics that require less frequent dosing. In December 2025, Prolynx announced the appointment of Chris Boulton as Chief Executive Officer, a leadership change as it advances its weight-loss drug pipeline.